文献速递心血管CT

CAD-RADS中高危斑块在心脏CT血管造影中的报告趋势及临床影响

Reporting trends and clinical impact of high-risk coronary plaques on cardiac CT angiography in CAD-RADS.
PubMed 文献 · Eur Radiol · 2025-07-30

该回顾性研究纳入21503例心脏CT血管造影病例,评估CAD-RADS高危斑块修饰词报告趋势及临床影响。仅169例(0.8%)报告高危斑块,报告率因读者和临床场景而异;在疑似稳定心绞痛患者中,高危斑块报告组更常接受有创冠状动脉造影、负荷试验和血运重建。

要点

  • CAD-RADS高危斑块修饰词报告率低(0.8%),且在不同阅片者间差异大(0.1%-1.3%)。
  • 报告高危斑块与后续更频繁的有创冠状动脉造影、负荷试验和血运重建相关。
  • 高危斑块报告率随冠状动脉钙化或CAD-RADS分级升高而增加。

核心结论

  • CAD-RADS修饰词高危斑块影响了冠心病患者的管理,但其报告率低且因阅片者和临床场景而异。

研究设计与样本

  • 回顾性研究,纳入2017年10月至2021年12月期间三级转诊医院的心脏CT血管造影放射报告共21503例(平均年龄62.7岁±12.3[SD];11127例男性)。

临床应用与阅片要点

  • 在疑似稳定心绞痛患者中,报告高危斑块组较未报告组更常进行有创冠状动脉造影(CAD-RADS 1-2:8.8% vs 1.4%;p=0.01)。
  • 在疑似稳定心绞痛患者中,报告高危斑块组较未报告组更常进行负荷试验(CAD-RADS 3:38.5% vs 18.4%;p=0.02)。
  • 在疑似稳定心绞痛患者中,报告高危斑块组较未报告组更常进行冠状动脉血运重建(CAD-RADS 3:23.1% vs 8.7%;p=0.02;CAD-RADS 4-5:75.0% vs 54.6%;p=0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the reporting trends and clinical impact of the CAD-RADS modifier high-risk plaque (HRP).

MATERIALS AND METHODS: Radiology reports of cardiac CT angiography performed in a tertiary referral hospital between October 2017 and December 2021 were retrospectively reviewed. Cases coded with modifier HRP or with CT reports mentioning HRP were defined as "HRP-reported." The prevalence of HRP-reported cases was analyzed. Subsequent management within 90 days post-CT was reviewed for cases with suspected stable angina.

RESULTS: Among the 21503 cases (mean age, 62.7 years ± 12.3 [SD]; 11,127 men) enrolled, 169 cases (0.8%) were HRP-reported. HRP-reported cases were more frequent in cases with suspected acute coronary syndrome or stable angina than others (1.2% vs. 1.1% vs. 0.1%; p < 0.001), protocols for coronary CT angiography or triple-rule-out CT, compared to others (1.1% vs. 0.7% vs. 0.1%; p < 0.001), and cases with higher coronary artery calcium or CAD-RADS categories (p for trends < 0.001). HRP reporting rates varied among the readers, ranging from 0.1 to 1.3%. In the setting of suspected stable angina, the HRP-reported group more frequently underwent invasive coronary angiography in CAD-RADS 1-2 (8.8% vs. 1.4%; p = 0.01), stress testing in CAD-RADS 3 (38.5% vs. 18.4%; p = 0.02), and coronary revascularization in CAD-RADS 3 (23.1% vs. 8.7%; p = 0.02) or 4-5 (75.0% vs. 54.6%; p = 0.001).

CONCLUSION: The CAD-RADS modifier HRP impacted the management of patients with CAD. However, its reporting prevalence was low and varied depending on the readers and clinical settings.

KEY POINTS: Question Data on the real-world clinical use of CAD-RADS high-risk plaque features on cardiac CT angiography are limited. Findings The reporting prevalence of high-risk plaque was low and varied among radiologists and clinical settings in a large academic hospital. Clinical relevance This study reveals the underreporting and variability in reporting practices of high-risk plaque on cardiac CT angiography, despite its importance in managing patients with coronary artery disease.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yoo WS, Suh YJ, Lee S, et al. Reporting trends and clinical impact of high-risk coronary plaques on cardiac CT angiography in CAD-RADS. Eur Radiol. 2025. PMID: 40739055. doi:10.1007/s00330-025-11872-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。